12 July 2020>: Database Analysis
Clinical Features and Prognosis of Merkel Cell Carcinoma in Elderly Patients
YiJun Xia 1ABE , DongSheng Cao 1BD , Jun Zhao 2C , BangZhong Zhu 1D , Juan Xie 1ADEF*DOI: 10.12659/MSM.924570
Med Sci Monit 2020; 26:e924570
Table 2 Survival rates of Merkel cell cancer patients stratified by age.
Variables | Age | P value | |
---|---|---|---|
65–80 years | >80 years | ||
Overall survival | |||
1-year OS (95% CI) | 84.8% (82.6%–87.0%) | 67.8% (64.7%–70.9%) | |
3-year OS (95% CI) | 63.0% (59.9%–66.1%) | 39.2% (35.7%–42.7%) | |
5-year OS (95% CI) | 54.8% (51.1%–58.5%) | 24.7% (20.6%–28.8%) | |
Median OS (months) | 66.0 | 25.0 | |
MCC-specific survival | 0.087 | ||
1-year MSS (95% CI) | 92.6% (91.0%–94.2%) | 89.8% (87.6%–92.0%) | |
3-year MSS (95% CI) | 81.9% (79.2%–84.6%) | 80.3% (77.0%–83.6%) | |
5-year MSS (95% CI) | 80.1% (77.2%–83.0%) | 76.2% (71.3%–81.1%) | |
Median MSS (months) | 69.7 | 66.9 | |
OS – overall survival; MSS – MCC-specific survival. |